#biotech نتائج البحث
SELLAS Life Sciences $SLS to host a virtual R&D Day on Oct 29, 2025 ahead of Phase 3 REGAL trial results due by year-end. Event to feature top AML expert Dr. Omer Jamy and updates on GPS and SLS009 programs. Pivotal moment ahead for the biotech. #Biotech #SLS #AML #Stocks
Oxford BioDynamics' Bartu Ahiska on breakthrough CFS test @OxBioDynamics proactiveinvestors.com/companies/news… #Health #Biotech
🚀 QSI (Quantum-Si) عند 1.75$ (+13.9%) •إطلاق V4 Sequencing Kit أعطى دفعة قوية 🔬 •السهم يحافظ على دعم 1.70$ •مقاومة مهمة عند 2.50$ واختراقها قد يشعل موجة صعودية #Stocks #Biotech $QSI
Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back. $XBI #biotech barrons.com/articles/biote…
Biotech Stocks Surge After Hours On Trial Updates, Data Momentum dlvr.it/TNfn20 #Biotech #Stocks #Investing #MarketNews #HealthTech
This #CU6 H2H study was supposed to be some sort of $TLX killer but - acknowledging I don’t understand #biotech well - the release reads underwhelming (and no quotes from Prof Emmett?). Market seems to agree, -10% although is this just sell-the-news after a big recovery run? 🤔
$MYNZ gaining attention — low float biotech with real growth story. CMS review + FDA filing ahead could open a $18B market. Smart positioning before momentum builds. 🌱 #MYNZ #Biotech #GrowthStocks
Another small milestone on the way to my next big goal - 10,000 followers. 💪 Thank you all, I hope you enjoy my posts. #Biotech $XBI
#Biotech and #Healthcare are among the sectors held relatively well, during the last 5 days! $IBB $XLV
Not all psychedelics need to induce hallucinations. New compounds are being designed to harness neuroplasticity without the trip. 🔗 wired.com/story/a-startu… #Psychedelics #Biotech #MentalHealth
🚀 $GV just locked in GLOBAL rights to stem cell tech that could CURE diabetes—remission in trials for Type 1/2! 540M patients, $150B market. From insulin hell to beta-cell regen magic. Who's betting on the breakout? 📈 #WeBull / 4hr SS #Biotech #DiabetesCure #GV #pennystocks 🤔
Big move for $OVID (+12.2%). Co. develops drugs for epilepsy & neurological disorders. Today's volume was huge. High-risk, high-reward potential. #Biotech #TradingMevXBNB
Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial globenewswire.com/news-release/2… $QNTM #Biotech #Nasdaq #Multiplesclerosis #Neurodegenerative #MS #MSawareness #Lifescience
“Our data is very compelling” — Cantargia’s CEO Hilde Steineger shares bold perspectives on the company’s scientific foundation, strategic direction & clinical momentum. biostock.se/2025/10/cantar… #biotech #Cantargia #LifeSciences
Scientists have built “invisible” immune cells that can wipe out #cancer while hiding from the body’s defenses. A leap toward universal, off-the-shelf #immunotherapy. #Biotech #health 👉 Read: shorturl.at/o9edq @technicitymag @gvalan @DrFerdowsi @junjudapi @mary_gambara
🧠 Today is #WorldMentalHealthDay. Nearly 60M Americans live with anxiety, depression, PTSD & other mental illnesses. Their diseases can be debilitating, and too often, stigmatized. #Biotech innovators are working to develop new treatments. You may be helping. 🎥 See how:
Psychedelics is not a silver bullet, but it does have promise. Dr. Johnson talks about the realistic possibilities of psychedelics in medicine. @Drug_Researcher #Alphanooner #psychedelics #biotech
StockWatch: Novo Nordisk Raises MASH Bet with Up-to-$5.2B Akero Acquisition sfbn.org/san-francisco-… #biotech #news
sfbn.org
StockWatch: Novo Nordisk Raises MASH Bet with Up-to-$5.2B Akero Acquisition - San Francisco...
If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B) saw a competitor’s bet and raised the stakes...
Biotech Stocks Surge After Hours On Trial Updates, Data Momentum dlvr.it/TNfn20 #Biotech #Stocks #Investing #MarketNews #HealthTech
Sequels, Reboots, Franchises, Oh My! Why Does Pop Culture Feel So Unoriginal? sdbn.org/san-diego-biot… #news #biotech
Swedish AI breakthrough: Blood test predicts severe liver disease more than 5 years in advance using biomarkers. Early detection could significantly reduce healthcare costs worldwide. Developing precision medicine. sciencedaily.com/releases/2025/… #Biotech #HealthTech #ScienceNews
$XBI $IBB #biotech "... big reason ...Big #Pharma companies are in dire need of drugs to pad their pipelines, $PFE, $MRK, and Bristol Myers Squibb $BMY contend with looming patent cliffs" ↔️ $NTLA $LEGN $RGNX $Edit $Iova barrons.com/articles/biote…
MWBN Jobs: Scientist – MQO Corporate Safety, QA – Indianapolis, IN #biotech #jobs mwbn.bio/midwest-life-s…
The #biotech scorecard for the fourth quarter: 36 stock-moving events to watch via @statnews #healthcare monkeylink.co/059abe
🚀 Exciting news in the biotech world! SG’s Nanyang Biologics is set to list on Nasdaq with a whopping $1.5B valuation! What do you think this means for the future of biotech investments? 🤔 Dive into the details here: ift.tt/Dse69yH #Biotech #Investing #Nasdaq #Innova…
This #CU6 H2H study was supposed to be some sort of $TLX killer but - acknowledging I don’t understand #biotech well - the release reads underwhelming (and no quotes from Prof Emmett?). Market seems to agree, -10% although is this just sell-the-news after a big recovery run? 🤔
MWBN Jobs: Cellular Therapy Faculty – Pathology – Kansas City, KS 66160 #biotech #jobs mwbn.bio/midwest-life-s…
This has to impact #geneTherapy #biotech 📈 $XBI $IBB $ArkG
Large Pharma accelerates U.S. manufacturing investments to mitigate upcoming tariffs - Announced ~$368B of planned investments in U.S. manufacturing, with nearly half having already announced breaking ground Source: William Blair
ReNerve has secured first sales of its EmpliQ amniotic tissue products. #ASX #health #biotech $RNV stockhead.com.au/stockhead-tv/s…
Feeling the need for speed? 🏎️ Radiance ECL gets you brilliant, sensitive detection in no time. Less waiting, more data. #ECL #FastResults #Biotech #azurebiosystems
MWBN Jobs: Senior Therapeutic Area Specialist, Cardiovascular Community – Kansas City W, KS – Kansas City, KS #biotech #jobs mwbn.bio/midwest-life-s…
$XBI $SLS 009, 41%+ survival. 46% combo 009/Venetoclax Venetoclax annual sales, $2.5 billion 009 Increases usage/time, elevates sales 009 a threat & opportunity, BAT/SOC For @Roche & @abbvie to cough up 20$ per share for 009 - should be a no-brainer #biotech #Bioshield
MWBN News: Senior Therapeutic Area Specialist, Cardiovascular Community – Kansas City W, KS – Kansas City, KS – Indeed.com #biotech #news mwbn.bio/midwest-life-s…
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025” bcbn.org/boston-cambrid… #news #biotech
Inside Sutter Health’s first facility of its new $800M Santa Clara campus sfbn.org/san-francisco-… #news #biotech
MWBN News: Cellular Therapy Faculty – Pathology – Kansas City, KS 66160 – Indeed.com #biotech #news mwbn.bio/midwest-life-s…
This #CU6 H2H study was supposed to be some sort of $TLX killer but - acknowledging I don’t understand #biotech well - the release reads underwhelming (and no quotes from Prof Emmett?). Market seems to agree, -10% although is this just sell-the-news after a big recovery run? 🤔
Big move for $OVID (+12.2%). Co. develops drugs for epilepsy & neurological disorders. Today's volume was huge. High-risk, high-reward potential. #Biotech #TradingMevXBNB
$COSM FULL BLOWN #PHARMA #BIOTECH company making a wild bet into crypto $300M financing facility, 72% of each tranche going towards crypto asset treasury. Made initial purchase of $ETH, watch for more This could make headlines in the stock market realm⏳
How high can $COSM go? Answer: No clue! $SBET and $QMMM had a very similar situation, for reference QMMM stock went soaring from $14 to $303 and from SBET from $6 to $124
Product differentiation is more important than classical drug models indicate. First-in-class will retain larger share if later entrants are not differentiated while a differentiated drug will gain outsized share even if a later entrant #learnbiotechinvesting #biotech #investing…
Another day, another IPO. We're proud to unveil the pending public offering of @CivilizationVC portfolio company @BillionToOneInc, a diagnostics rocketship. 🚀🧬 We were the first check into the company in 2017 - and I believe the only #lifesciences #healthtech #biotech…
#aelisfarma #biotech #cellectis #adocia #trading 📢 AEF0217 / ICOD – Démarrage imminent ! 🔹 Événement le 1er octobre 2025 à Troina (IRCCS Oasi) 🔹 Centre impliqué dans la phase 2b d’AEF0217 (trisomie 21) 🔹 Collaboration avec l’Univ. de Catane 🔹 200 patients en recrutement
We're at BioJapan 2025! Stop by our booth and learn about our antibody discovery and characterization services. 📅 Oct 8 - 10 📍Booth B-110, Ontario Pavilion #BioJapan2025 #biotech #AntibodyDiscovery #AntibodyCharacterization
..and before you know it, it’s already the final day of #BioJapan / Regenerative Medicine JAPAN / healthTECH JAPAN 2025 ! We hope everyone has been having a phenomenal event so far and makes the most of the time that’s left! jcd-expo.jp/en/ #BioJapan2025 #biotech #pharma
$MYNZ gaining attention — low float biotech with real growth story. CMS review + FDA filing ahead could open a $18B market. Smart positioning before momentum builds. 🌱 #MYNZ #Biotech #GrowthStocks
Tomorrow is the day! Register here: biojapan2025.jcdbizmatch.jp/en/Registration We hope you enjoy the Exhibition, Seminars, and Partnering over the next three days and make many valuable connections! #BioJapan #BioJapan2025 #biotech #biotechnology #pharma #regenerativemedicine #biomanufacturing
Meet the 10 startups selected for the Startup Pitch Competition at #LSIF2025 hosted by KAIMRC in collaboration with JP Morgan Asset Management and MISA— bringing bold science, smart therapeutics, and game-changing technologies to Saudi Arabia. #Biotech #LifeSciences…
$TCRX is advancing next-gen TCR-T cell therapies for solid tumors. Q2 revenue of $3.1M beat expectations, and a recent $30M direct offering extends their cash runway into 2027. Keep an eye on upcoming clinical data from their TSC-200 program. #Biotech #CellTherapy
Not all psychedelics need to induce hallucinations. New compounds are being designed to harness neuroplasticity without the trip. 🔗 wired.com/story/a-startu… #Psychedelics #Biotech #MentalHealth
🚀 QSI (Quantum-Si) عند 1.75$ (+13.9%) •إطلاق V4 Sequencing Kit أعطى دفعة قوية 🔬 •السهم يحافظ على دعم 1.70$ •مقاومة مهمة عند 2.50$ واختراقها قد يشعل موجة صعودية #Stocks #Biotech $QSI
Startup’s ‘brain shuttle’ tech is designed to efficient, repeatable delivery of genetic medicines across the blood–brain barrier. longevity.technology/news/aerska-em… #longevity #investment #biotech #RNAi #Alzheimers #Parkinsons
$ESPR surges 6.5% after settling patent litigation with Dr. Reddy's, securing no generic competition for its cholesterol drugs Nexletol/Nexlizet until April 2040. This follows similar settlements, clearing a major overhang. Stock up 32% YTD. 🚀 #ESPR #Biotech
Thank you to everyone who met with Novotech at BioJapan 2025. Our team was pleased to connect with sponsors exploring clinical development across Asia-Pacific and beyond. If we missed you: ow.ly/VxeJ50Xalwn #BioJapan2025 #Novotech #Biotech
Big move by $BIOV $BVAXF bringing in a former Sanofi vaccines exec to the board. Adds major credibility and experience as they ramp up the DPX platform across cancer and allergy programs. Strong signal of where this is heading. #Biotech #Vaccines #Immunotherapy #DPX
Something went wrong.
Something went wrong.
United States Trends
- 1. Bears 79.7K posts
- 2. Jake Moody 10.8K posts
- 3. Falcons 47.5K posts
- 4. Snell 20.1K posts
- 5. Bills 135K posts
- 6. Josh Allen 24K posts
- 7. Caleb 43.1K posts
- 8. Swift 285K posts
- 9. #BearDown 1,800 posts
- 10. #Dodgers 13.9K posts
- 11. Jayden Daniels 9,712 posts
- 12. Turang 3,838 posts
- 13. Bijan 29.8K posts
- 14. Ben Johnson 3,478 posts
- 15. #NLCS 12.8K posts
- 16. phil 152K posts
- 17. Roki 5,661 posts
- 18. #RaiseHail 8,003 posts
- 19. Brewers 45.1K posts
- 20. AFC East 8,845 posts